Amarin’s Vazkepa gets green light from SMC by John Pinching | Aug 9, 2023 | News | 0 Treatment will help reduce the risk of heart attacks and strokes for patients across Scotland Read More
Amarin’s Vazkepa secures NICE recommendation by John Pinching | Jun 13, 2022 | News | 0 It is the first treatment in its class to receive NICE approval for cardiovascular risk reduction Read More
MHRA authorises Amarin’s heart drug Vazkepa by Lucy Parsons | Apr 23, 2021 | News | 0 Drug demonstrated a 25% relative risk reduction in the first occurrence of major adverse cardiovascular events in REDUCE-IT trial Read More
Kesimpta and Vazkepa among latest CHMP recommendations by Lucy Parsons | Feb 1, 2021 | News | 0 Bumper meeting saw 13 new medicines recommended for approval Read More